Barclays Maintains Overweight on Newmark Group, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Negative 87.8%

Neg 87.8% Neu 0% Pos 0%

Barclays analyst Brendan Lynch maintains Newmark Group (NASDAQ:NMRK) with a Overweight and lowers the price target from $21 to $19.